Jennifer Spinato, APRN
Adult Health · Las Vegas, NVNPI 1164761334
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 69 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Medtronic at 52.2% of the total. Reporting peaked in 2021 at $708 and has fallen 58.4% since, to $294 in 2025.
Across 69 payments — averaging $23.06 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medtronic$830
- Abiomed$361
- La Jolla Pharmaceutical Company$222
- AbbVie$66
- Melinta Therapeutics, LLC$52
- Getinge USA Sales, LLC$46
- plus $14 from 1 others
What the payments were for
- Food & beverage$1,591100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medtronic | 53 | $830 |
| Abiomed | 3 | $361 |
| La Jolla Pharmaceutical Company | 6 | $222 |
| AbbVie | 3 | $66 |
| Melinta Therapeutics, LLC | 2 | $52 |
| Getinge USA Sales, LLC | 1 | $46 |
| Aimmune Therapeutics, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Impella$275
How this compares
$1,591 in reported general payments places this provider in the 65th percentile of 90 adult health providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Daptomycin | 117 | $171,610 |
| ErtapenemErtapenem Sodium | 28 | $22,312 |
| Cefepime Hcl | 83 | $14,643 |
| CeftriaxoneCeftriaxone Sodium | 27 | $3,431 |
| Doxycycline Hyclate | 45 | $2,511 |
| Vancomycin Hcl | 17 | $1,969 |
| Linezolid | 11 | $576 |
| Azithromycin | 23 | $539 |
| Fluconazole | 33 | $476 |
| Rifampin | 13 | $451 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 28 | $394 |
| Nystatin-TriamcinoloneNystatin/Triamcinolone Acet | 11 | $257 |
| Nystatin | 22 | $230 |
| Ciprofloxacin Hcl | 27 | $173 |
| Levofloxacin | 25 | $154 |
Paid to pharmacies, not to this prescriber.
Other adult health in Las Vegas
- Marcia Castro-RosenbergLas Vegas$64K
- Amanda SquiersLas Vegas$36K
- Jasmina FornbacherLas Vegas$14K
- Marcella PomeranzLas Vegas$14K
- Karisa SonLas Vegas$10K
- Jessica LuceroLas Vegas$6K
- Monica LynamLas Vegas$5K
- Thomas McNeilLas Vegas$5K
- Roger ConantLas Vegas$4K
- Ruth RamirezLas Vegas$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.